In-licensing and out-licensing of complex, interrelated and cross-disciplinary technologies are increasingly important elements of our clients’ business strategies. Leveraging technical knowledge, business acumen and legal experience, we structure, prepare and negotiate thousands of licenses and other technology transactions each year, from the perspectives of both the licensor and the licensee. We advise clients on the licensing of technical know-how, trade secrets, patents, trademarks, copyrights and most other forms of intellectual property—relating to computer software, biotechnology and pharmaceuticals, manufacturing designs, digital content and many other technologies. We also have extensive domestic and international experience with software shrink-wrap and click-through agreements, and with strategic collaborations, research transactions and other technology transfers.
In this area, we have:
- Assisted Nano-C Corporation in licensing projects involving domestic and foreign companies using fullerene combustion technology
- Represented Eyetech Pharmaceuticals in its $750 million collaboration and license agreements with Pfizer to develop and commercialize ophthalmic products for the treatment of blindness—a strategic alliance selected by Recombinant Capital for its Breakthrough Alliance Award
- Identified significant potential licensees and negotiated commercial agreements on behalf of a client with a large patent portfolio in the field of camera image presentation and processing